Verition Fund Management
OCEA

Verition Fund Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Verition Fund Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-58,159
Closed -$71K – 3565
2024
Q2 		$71K Buy
58,159
+44,519
+326% +$75.9K ﹤0.01% 2768
2024
Q1 		$51.6K Sell
13,640
-2,370
-15% -$4.46K ﹤0.01% 2630
2023
Q4 		$10.6K Buy
+16,010
New +$22K ﹤0.01% 2230

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Verition Fund Management's OCEA Position: Q3 2024 in Review

Verition Fund Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2024, closing a stake of 58,159 shares — an estimated $71K sold.

Verition Fund Management first reported a position in OCEA in Q4 2023 and held it in 3 quarters. The position peaked at $71K in Q2 2024. 21 funds tracked by Wall St. Rank hold OCEA as of Q3 2024.

  • Verition Fund Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 58,159 Ocean Biomedical, Inc. Common Stock shares in Q3 2024, an estimated $71K.
  • Verition Fund Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Verition Fund Management's Ocean Biomedical, Inc. Common Stock position peaked at $71K in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.